Regulatory guidance documents impact various stages of drug development, from preclinical research to post-marketing surveillance. They help define the clinical trial endpoints, determine the statistical methods to be used, and ensure ethical considerations are met. By following these guidelines, researchers can more effectively demonstrate the safety and efficacy of new treatments, facilitating faster review and approval by regulatory bodies.
